Univ Tx Sw Medctr Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNIV TX SW MEDCTR, and what generic and branded alternatives to UNIV TX SW MEDCTR drugs are available?
UNIV TX SW MEDCTR has two approved drugs.
Drugs and US Patents for Univ Tx Sw Medctr
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univ Tx Sw Medctr | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 210265-001 | Feb 6, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Univ Tx Sw Medctr | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 209507-001 | Nov 1, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.